The oxidized low-density lipoprotein receptor mediates vascular effects of inhaled vehicle emissions

Am J Respir Crit Care Med. 2011 Jul 1;184(1):82-91. doi: 10.1164/rccm.201012-1967OC. Epub 2011 Apr 14.

Abstract

Rationale: To determine vascular signaling pathways involved in inhaled air pollution (vehicular engine emission) exposure-induced exacerbation of atherosclerosis that are associated with onset of clinical cardiovascular events.

Objectives: To elucidate the role of oxidized low-density lipoprotein (oxLDL) and its primary receptor on endothelial cells, the lectin-like oxLDL receptor (LOX-1), in regulation of endothelin-1 expression and matrix metalloproteinase activity associated with inhalational exposure to vehicular engine emissions.

Methods: Atherosclerotic apolipoprotein E knockout mice were exposed by inhalation to filtered air or mixed whole engine emissions (250 μg particulate matter [PM]/m(3) diesel + 50 μg PM/m(3) gasoline exhausts) 6 h/d for 7 days. Concurrently, mice were treated with either mouse IgG or neutralizing antibodies to LOX-1 every other day. Vascular and plasma markers of oxidative stress and expression proatherogenic factors were assessed. In a parallel study, healthy human subjects were exposed to either 100 μg PM/m(3) diesel whole exhaust or high-efficiency particulate air and charcoal-filtered "clean" air (control subjects) for 2 hours, on separate occasions.

Measurements and main results: Mixed emissions exposure increased oxLDL and vascular reactive oxygen species, as well as LOX-1, matrix metalloproteinase-9, and endothelin-1 mRNA expression and also monocyte/macrophage infiltration, each of which was attenuated with LOX-1 antibody treatment. In a parallel study, diesel exhaust exposure in volunteer human subjects induced significant increases in plasma-soluble LOX-1.

Conclusions: These findings demonstrate that acute exposure to vehicular source pollutants results in up-regulation of vascular factors associated with progression of atherosclerosis, endothelin-1, and matrix metalloproteinase-9, mediated through oxLDL-LOX-1 receptor signaling, which may serve as a novel target for future therapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Air Pollutants / adverse effects*
  • Animals
  • Antibodies, Neutralizing / pharmacology
  • Aorta / metabolism*
  • Apolipoproteins E / genetics
  • Atherosclerosis / metabolism
  • Endothelin-1 / metabolism
  • Endothelium, Vascular / metabolism
  • Humans
  • Lipid Peroxidation
  • Lipoproteins, LDL / metabolism
  • Male
  • Matrix Metalloproteinase 9 / metabolism
  • Mice
  • Mice, Knockout
  • Oxidative Stress
  • Reactive Oxygen Species / metabolism
  • Scavenger Receptors, Class E / blood
  • Scavenger Receptors, Class E / immunology
  • Scavenger Receptors, Class E / metabolism*
  • Signal Transduction
  • Thiobarbituric Acid Reactive Substances / metabolism
  • Up-Regulation
  • Vehicle Emissions*
  • Young Adult

Substances

  • Air Pollutants
  • Antibodies, Neutralizing
  • Apolipoproteins E
  • Endothelin-1
  • Lipoproteins, LDL
  • OLR1 protein, human
  • Olr1 protein, mouse
  • Reactive Oxygen Species
  • Scavenger Receptors, Class E
  • Thiobarbituric Acid Reactive Substances
  • Vehicle Emissions
  • oxidized low density lipoprotein
  • Matrix Metalloproteinase 9